Safety and Pharmacokinetics of Patanase in Pediatric Patients 2 to < 6 Years of Age

Summary

The purpose of the study is to assess the safety of the study drug, Patanase (Olopatadine Hydrochloride Nasal Spray 0.6%) compared to placebo (inactive substance) in children ages 2 to less than 6 who have a history of nasal allergies, and to assess the pharmcokinetics (study of the action of a drug in the body) in these children

Timeline

Start

2008-10

Primary completion

2008-12

Completion

—

Drugs

Indications